17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ESU Courses, 18 March<br />

ESU Course 31<br />

12.00 - 14.00 Current concepts and controversy in the diagnosis and management of<br />

upper tract urothelial carcinoma (UTUC)<br />

Green Hall 1 - Level N-1<br />

Epidemiology, diagnosis, evaluation<br />

M. Roupret, Paris (FR)<br />

Prognostic and predictive factors, pathology<br />

S.F. Shariat, New York (US)<br />

Chair: S.F. Shariat, New York (US)<br />

Treatment of low risk cancer (high grade Ta, T1 and CIS)<br />

M. Roupret, Paris (FR)<br />

Treatment of localized high risk (invasive) and metastatic cancer<br />

S.F. Shariat, New York (US)<br />

Aims and objectives<br />

Upper tract urothelial carcinoma (UTUC) is an uncommon disease with little evidence-based data to<br />

guide clinical decision-making. Recently, the tools available for the diagnosis and management of UTUC<br />

have improved significantly, complementing a growing understanding of the biology of this disease. UTUC<br />

requires appropriate management at all stages, since both the cure rate and morbidity are very sensitive<br />

to nuances of treatment. Yet proper risk stratification remains a challenge owing to the difficulty of clinical<br />

staging. This course will address contemporary concepts and controversies, including the timely and accurate<br />

diagnosis of UTUC, emphasizing the integration of pathologic and radiographic variables for appropriate<br />

risk stratification. Important features regarding the natural history of UTUC will also be emphasized; the<br />

role of imaging and endoscopy in clinical decision making, diagnosis, staging and follow-up; and, common<br />

pathways of metastatic spread. Up-to-date information regarding boundaries of surgical resection, indication<br />

and extent of lymphadenectomy, clinical staging of UTUC, and the role of neoadjuvant chemotherapy in<br />

patients with high risk UTUC will be detailed. Patient selection and treatment options for patients with UTUC<br />

such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy will<br />

be discussed.<br />

Objectives: After attending this course, participants should be able to:<br />

• identify problems associated with clinical staging of UTUC<br />

• illustrate importance of accurate staging techniques and their role in clinical decision making maximize<br />

ureteroscopic diagnostic biopsy and tumor resection<br />

• be aware of newer modalities such as endoluminal ultrasound and other novel staging methods<br />

• cite current concepts and controversies in the management of low-stage and high-stage UTUC<br />

• discuss and compare the risk, benefit, and side effects of laparoscopic and open radical<br />

nephroureterectomy<br />

• understand the management of the bladder cuff<br />

• understand the current role of multimodal therapy for high risk patients- integration of systemic therapy –<br />

neo-adjuvant vs. adjuvant treatment<br />

• discuss the need and boundaries of the recommended lymph node dissection<br />

<strong>EAU</strong> Milan <strong>2013</strong><br />

361<br />

ESU Courses

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!